Sharon N. Teraoka

2.0k total citations
27 papers, 1.3k citations indexed

About

Sharon N. Teraoka is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Sharon N. Teraoka has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Genetics and 12 papers in Cancer Research. Recurrent topics in Sharon N. Teraoka's work include BRCA gene mutations in cancer (17 papers), DNA Repair Mechanisms (16 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Sharon N. Teraoka is often cited by papers focused on BRCA gene mutations in cancer (17 papers), DNA Repair Mechanisms (16 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Sharon N. Teraoka collaborates with scholars based in United States, Denmark and Canada. Sharon N. Teraoka's co-authors include Patrick Concannon, Richard A. Gatti, Kathleen E. Malone, Jonine L. Bernstein, Ewa Bernatowska, Suna Önengüt, Aslıhan Tolun, Leslie Bernstein, Teresa Liang and Luciana Chessa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Sharon N. Teraoka

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon N. Teraoka United States	18	830	627	497	362	167	27	1.3k
Reinhard Kalb Germany	16	1.9k 2.3×	527 0.8×	451 0.9×	341 0.9×	117 0.7×	25	2.1k
Kelly Gonzalez United States	13	413 0.5×	423 0.7×	248 0.5×	267 0.7×	110 0.7×	18	943
Bernard Peissel Italy	21	942 1.1×	948 1.5×	208 0.4×	253 0.7×	265 1.6×	63	1.7k
Daphne Morrell United States	8	1.0k 1.3×	536 0.9×	568 1.1×	579 1.6×	289 1.7×	13	1.6k
David Bertwistle United Kingdom	15	1.6k 1.9×	577 0.9×	252 0.5×	576 1.6×	123 0.7×	41	1.9k
Ziedulla Abdullaev United States	19	1.8k 2.2×	556 0.9×	217 0.4×	227 0.6×	157 0.9×	28	2.2k
Michelle Le Beau United States	8	1.2k 1.4×	270 0.4×	360 0.7×	368 1.0×	60 0.4×	9	1.3k
Sarah Reid United Kingdom	8	1.2k 1.4×	929 1.5×	447 0.9×	394 1.1×	269 1.6×	10	1.7k
P.J. Byrd United Kingdom	13	1.0k 1.2×	221 0.4×	411 0.8×	501 1.4×	212 1.3×	16	1.3k
April N. Meyer United States	22	1.2k 1.5×	310 0.5×	169 0.3×	376 1.0×	56 0.3×	38	1.6k

Countries citing papers authored by Sharon N. Teraoka

Since Specialization

Citations

This map shows the geographic impact of Sharon N. Teraoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon N. Teraoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon N. Teraoka more than expected).

Fields of papers citing papers by Sharon N. Teraoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon N. Teraoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon N. Teraoka. The network helps show where Sharon N. Teraoka may publish in the future.

Co-authorship network of co-authors of Sharon N. Teraoka

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon N. Teraoka. A scholar is included among the top collaborators of Sharon N. Teraoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon N. Teraoka. Sharon N. Teraoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Meenal, Xiangfei Liu, Sharon N. Teraoka, et al.. (2021). Genes affecting ionizing radiation survival identified through combined exome sequencing and functional screening. Human Mutation. 42(9). 1124–1138. 1 indexed citations

Liu, Xiangfei, Sharon N. Teraoka, Jocyndra Wright, et al.. (2017). Identification of ATIC as a Novel Target for Chemoradiosensitization. International Journal of Radiation Oncology*Biology*Physics. 100(1). 162–173. 22 indexed citations

Martin, Nathan, Kotoka Nakamura, Jennifer M. P. Woo, et al.. (2014). Homozygous mutation of MTPAP causes cellular radiosensitivity and persistent DNA double-strand breaks. Cell Death and Disease. 5(3). e1130–e1130. 13 indexed citations

Brooks, Jennifer D., Leslie Bernstein, Sharon N. Teraoka, et al.. (2012). Variation in Genes Related to Obesity, Weight, and Weight Change and Risk of Contralateral Breast Cancer in the WECARE Study Population. Cancer Epidemiology Biomarkers & Prevention. 21(12). 2261–2267. 10 indexed citations

Capanu, Marinela, Patrick Concannon, Robert W. Haile, et al.. (2011). Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. Genetic Epidemiology. 35(5). 389–397. 13 indexed citations

Teraoka, Sharon N., Jonine L. Bernstein, Anne S. Reiner, et al.. (2011). Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Research. 13(6). R114–R114. 29 indexed citations

Malone, Kathleen E., Colin B. Begg, Robert W. Haile, et al.. (2010). Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation inBRCA1orBRCA2. Journal of Clinical Oncology. 28(14). 2404–2410. 126 indexed citations

Figueiredo, Jane C., Jennifer D. Brooks, David V. Conti, et al.. (2010). Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Research and Treatment. 127(3). 819–829. 11 indexed citations

Reding, Kerryn W., Jonine L. Bernstein, Bryan Langholz, et al.. (2010). Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Research and Treatment. 123(2). 491–498. 43 indexed citations

10.

Figueiredo, Jane C., Robert W. Haile, Leslie Bernstein, et al.. (2009). Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Research and Treatment. 120(1). 175–183. 19 indexed citations

11.

Concannon, Patrick, Robert W. Haile, Anne‐Lise Børresen‐Dale, et al.. (2008). Variants in the ATM Gene Associated with a Reduced Risk of Contralateral Breast Cancer. Cancer Research. 68(16). 6486–6491. 31 indexed citations

12.

Bernstein, Jonine L., Sharon N. Teraoka, Melissa C. Southey, et al.. (2006). Population-based estimates of breast cancer risks associated withATMgene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Human Mutation. 27(11). 1122–1128. 72 indexed citations

13.

Bernstein, Jonine L., Sharon N. Teraoka, Esther M. John, et al.. (2006). The CHEK2*1100delC Allelic Variant and Risk of Breast Cancer: Screening Results from the Breast Cancer Family Registry. Cancer Epidemiology Biomarkers & Prevention. 15(2). 348–352. 31 indexed citations

14.

Mitui, Midori, Ewa Bernatowska, Barbara Pietrucha, et al.. (2005). ATM Gene Founder Haplotypes and Associated Mutations in Polish Families with Ataxia‐Telangiectasia. Annals of Human Genetics. 69(6). 657–664. 33 indexed citations

15.

Bernstein, Jonine L., Sharon N. Teraoka, Robert W. Haile, et al.. (2003). Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Human Mutation. 21(5). 542–550. 42 indexed citations

16.

Chun, Helen H., Xia Sun, Shareef Nahas, et al.. (2003). Improved diagnostic testing for ataxia–telangiectasia by immunoblotting of nuclear lysates for ATM protein expression. Molecular Genetics and Metabolism. 80(4). 437–443. 64 indexed citations

17.

Teraoka, Sharon N., Kathleen E. Malone, David R. Doody, et al.. (2001). Increased frequency ofATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer. 92(3). 479–487. 93 indexed citations

18.

Teraoka, Sharon N., Milhan Telatar, Sara Becker-Catania, et al.. (1999). Splicing Defects in the Ataxia-Telangiectasia Gene, ATM: Underlying Mutations and Consequences. The American Journal of Human Genetics. 64(6). 1617–1631. 239 indexed citations

19.

Telatar, Milhan, Sharon N. Teraoka, Zhijun Wang, et al.. (1998). Ataxia-Telangiectasia: Identification and Detection of Founder-Effect Mutations in the ATM Gene in Ethnic Populations. The American Journal of Human Genetics. 62(1). 86–97. 121 indexed citations

20.

Wright, Jocyndra, Sharon N. Teraoka, Suna Önengüt, et al.. (1996). A high frequency of distinct ATM gene mutations in ataxia-telangiectasia.. PubMed. 59(4). 839–46. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact